BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (Nasdaq: SCMP), a Bio Pharma company developing prostone-based therapies for age-related and other diseases, today announced that its chief executive officer, Ryuji Ueno, M.D., Ph.D., Ph.D, will present at the 10th Annual BIO CEO & Investor Conference at the Waldorf Astoria Hotel in New York City at 1:15 p.m. (ET) on Tuesday, February 12, 2008. Dr. Ueno will provide a corporate overview, including a discussion of product development programs and recent corporate activities.
